UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: artifical intelligence

What is a Bioprocess Digital Twin?

Bioprocess digital twins are an exciting new technology that changes the way we do bioprocess development, process validation, and cGMP operations.

Read More

From data to discovery – the journey to digital innovation

Digital innovation in healthcare promises much. But potential and realisation are two very different things.

Researchers at Stanford in the US, for example, have developed an AI algorithm designed to diagnose skin cancer[1]. AI diagnosis was compared with that of 21 dermatologists and it matched the efficacy of its human counterparts. This has significant implications for patients, particularly those who find it difficult to access healthcare professionals. But the implications don’t stop there.

Read More

Big data, knowing and AI: do they influence drug discovery?

The quest for magic bullets started with Paul Ehrlich. He wanted to target the syphilis bacteria without harming the patients, which led to Salvarsan. Ehrlich was a foundational thinker, and we owe him modern concepts such as receptor and pharmacophore. His impact on the field – seeking the ideal molecules – pervades drug discovery.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive